InnovaRx Innova Health Strategies
Pricing Sign in

B44.0

Invasive pulmonary aspergillosis

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 7 never code together
B35-B49block
Excludes2
  • hypersensitivity pneumonitis due to organic dust (J67.-)J67.-
  • mycosis fungoides (C84.0-)C84.0-
A00-B99chapter
Excludes1
  • certain localized infections - see body system-related chapters
Excludes2
  • carrier or suspected carrier of infectious disease (Z22.-)Z22.-
  • infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium (O98.-)O98.-
  • infectious and parasitic diseases specific to the perinatal period (P35-P39)P35-P39
  • influenza and other acute respiratory infections (J00-J22)J00-J22

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 3
B44code
Includes
  • aspergilloma
A00-B99chapter
Includes
  • diseases generally recognized as communicable or transmissible
Use additional code
  • code to identify resistance to antimicrobial drugs (Z16.-)Z16.-
Index entries leading here 1
Alongside this code 5 same parent — B44
B44.1 Other pulmonary aspergillosis B44.2 Tonsillar aspergillosis B44.7 Disseminated aspergillosis B44.8 Other forms of aspergillosis category B44.9 Aspergillosis, unspecified
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC6 CMS28HCC6 ESRD21HCC6 ESRD24HCC6 RX08HCC5

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
B44
Block
B35-B49
Siblings
5

Present FY2024–FY2027.